von Willebrand factor and coronary heart disease: prospective study and meta-analysis

Eur Heart J. 2002 Nov;23(22):1764-70. doi: 10.1053/euhj.2001.3237.

Abstract

Aims: To determine whether circulating von Willebrand factor concentrations are prospectively related to risk of coronary heart disease in the general population.

Methods and results: We measured baseline von Willebrand factor values in the stored serum samples of 625 men with major coronary events and in 1266 controls 'nested' in a prospective study of 5661 men aged 40-59 years, recruited from general practices in 18 British towns in 1978-1980 and followed up for 16 years for fatal coronary heart disease and non-fatal myocardial infarction. We conducted a meta-analysis of previous relevant studies to place our results in context. Men in the top third of baseline von Willebrand factor values (tertile cutoff >126 IU.dl(-1)) had an odds ratio for coronary heart disease of 1.83 (95% confidence interval 1.43-2.35; 2P <0.0001) compared with those in the bottom third (tertile cutoff <90 IU.dl(-1)), after adjustments for age and town. The odds ratio was little changed after further adjustment for risk factors (1.82, 95% CI 1.37-2.41), and was not significantly different in an analysis restricted to the 404 cases and 1007 controls without baseline evidence of coronary heart disease (odds ratio 1.53, 95% CI 1.10-2.12). A meta-analysis of all relevant population-based prospective studies (including the present study) yielded a combined odds ratio of 1.5 (95% CI 1.1-2.0). von Willebrand factor values were strongly correlated with Helicobacter pylori seropositivity and circulating concentrations of C-reactive protein (2 P<0.0001 for each), but not with smoking, blood lipids, or most other measured risk factors.

Conclusion: Though circulating von Willebrand factor concentrations may be associated with incident coronary heart disease, further studies are needed to determine the extent to which this is causal.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens / analysis*
  • Biomarkers / blood
  • Case-Control Studies
  • Coronary Disease / blood*
  • Coronary Disease / drug therapy
  • Coronary Disease / etiology
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Risk Factors
  • von Willebrand Factor / immunology

Substances

  • Antigens
  • Biomarkers
  • Von Willebrand antigen
  • von Willebrand Factor